BIOTHRAX (anthrax vaccine)
ANTHRAX VACCINE · ANTHRAX VACCINATION
EMERGENT BIOSOL
Drug class
Anthrax Vaccine
Anthrax vaccines represent an active immunizing drug class composed of biological agents—primarily cell-free culture filtrates or purified recombinant forms containing the protective antigen protein of *Bacillus anthracis*. Read more about Anthrax Vaccine
2 drugs in this class 1 manufacturers
Drugs in Anthrax Vaccine
CYFENDUS (NATIONAL STOCKPILE) (anthrax vaccine adsorbed, adjuvanted)
ANTHRAX VACCINE · POST-EXPOSURE ANTHRAX PREVENTION
EMERGENT BIOSOL
Filter & compare in the drug finder →
Opens the drug finder with Anthrax Vaccine preselected. Add indication or manufacturer filters there.
Anthrax vaccines represent an active immunizing drug class composed of biological agents—primarily cell-free culture filtrates or purified recombinant forms containing the protective antigen protein of *Bacillus anthracis*.
Mechanistically, these formulations stimulate the host immune system to produce neutralizing antibodies against protective antigen, thereby preventing the toxin complex from binding to host cell receptors and arresting subsequent cellular toxicity.
The class is therapeutically indicated for both pre-exposure prophylaxis in individuals at high risk of occupational or biodefense exposure, and as post-exposure prophylaxis—administered alongside appropriate antimicrobial therapy—to prevent cutaneous, gastrointestinal, and systemic inhalational anthrax disease.
-
fda.gov
Anthrax vaccines represent an active immunizing drug class composed of biological agents—primarily cell-free culture filtrates or purified recombinant forms containing the protective antigen protein of *Bacillus anthracis* Mechanistically, these formulations stimulate the host immune system to produce neutralizing antibodies against protective antigen, thereby preventing the toxin complex from binding to host cell receptors and arresting subsequent cellular toxicity
-
cdc.gov
Anthrax vaccines represent an active immunizing drug class composed of biological agents—primarily cell-free culture filtrates or purified recombinant forms containing the protective antigen protein of *Bacillus anthracis*
-
fda.gov
Mechanistically, these formulations stimulate the host immune system to produce neutralizing antibodies against protective antigen, thereby preventing the toxin complex from binding to host cell receptors and arresting subsequent cellular toxicity
-
nih.gov
Mechanistically, these formulations stimulate the host immune system to produce neutralizing antibodies against protective antigen, thereby preventing the toxin complex from binding to host cell receptors and arresting subsequent cellular toxicity
-
fda.gov
The class is therapeutically indicated for both pre-exposure prophylaxis in individuals at high risk of occupational or biodefense exposure, and as post-exposure prophylaxis—administered alongside appropriate antimicrobial therapy—to prevent cutaneous, gastrointestinal, and systemic inhalational anthrax disease
-
cdc.gov
The class is therapeutically indicated for both pre-exposure prophylaxis in individuals at high risk of occupational or biodefense exposure, and as post-exposure prophylaxis—administered alongside appropriate antimicrobial therapy—to prevent cutaneous, gastrointestinal, and systemic inhalational anthrax disease
-
cdc.gov
The class is therapeutically indicated for both pre-exposure prophylaxis in individuals at high risk of occupational or biodefense exposure, and as post-exposure prophylaxis—administered alongside appropriate antimicrobial therapy—to prevent cutaneous, gastrointestinal, and systemic inhalational anthrax disease
Sign in to follow this class
Following a drug class requires a free Physicians Office Resource account.